• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Recovering Lost Therapeutic Opportunities in High-Risk Paediatric Cancer-Novel Drivers of Receptor Tyrosine Kinase Activation

Grant number: 109341 | Funding period: 2024 - 2027

Active

Related publications (3)

Scholarly works icon

A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation

LM Brown, G Tax, P Acera Mateos, A de Weck, S Foresto, T Robertson, F Jalud, P Ajuyah, P Barahona, J Mao, MEM Dolman, M Wong, C Mayoh, MJ Cowley, LMS Lau, T Sadras, PG Ekert

2025-12-01

Precision medicine programs like the Zero Childhood Cancer Program perform comprehensive molecular analysis of patient tumors, ena..

Scholarly works icon

PDGFRA in paediatric high-grade glioma – target or distraction?

N Le, J Chen, PG Ekert, LM Brown, N Manoharan

2025-11-01

Paediatric high-grade gliomas (pHGGs) are aggressive and molecularly heterogenous paediatric brain tumours with extremely poor sur..

Scholarly works icon

Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision

C Shembrey, R Yang, J Casan, W Hu, H Chen, GJ Singh, T Sadras, K Prasad, J Shortt, RW Johnstone, JA Trapani, PG Ekert, M Fareh

2024-12-20

Single-nucleotide variants (SNVs) are extremely prevalent in human cancers, although most of these remain clinically unactionable...

University of Melbourne Researchers

Teresa Sadras's Profile Picture
Teresa Sadras

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224